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ROS 的产生，在介导细胞坏死调控中起关键作用。此外 RIP3 参与的细胞坏死反
应可作为细胞死亡的备份方式，在细胞凋亡方式被抑制后启动细胞坏死清除入
侵病毒，在细胞免疫中发挥重要作用。在细胞死亡信号调节中，RIP3 如何协同



































Apoptosis and necrosis have long been considered key factors in normal 
development of higher organisms. Receptor-interacting protein 3 (RIP3) is involved 
in apoptosis signaling pathway . Recent studies have found that RIP3 functions as a 
molecular switch between apoptosis and necrosis and can activate key metabolic 
enzymes in mitochondrion to produce ROS, playing a key role in promote cell 
necrosis. Besides, RIP3 involved necrosis serves as a backup of cell death and can  
launch to clear intruding viruses when cell apoptosis is inhibited， playing an 
important role in cell immunity. In the regulation of cell death， questions，such as 
how RIP3 collaborates with other regulatory proteins to achieve its cellular 
functions，  how the individual domains of RIP3 function, as well as how RIP3 
recognize its downstream substrate such as MLKL, are to be solved. Acquiring high 
quality RIP3 in vitro is key to answer these questions，as well as investigation of 
protein structure and drug design of RIP3 and its family. Therefore,  we adopted 
prokaryotic protein expression system，successfully purified RIP3 kinase domain,  
and carried out primary analysis on its activity. First,  RIP3 protein sequence and 
domain was analyzed in silico. Combined with expression result of full-length RIP3 
in E. coli in initial trial, an expression screening library of RIP3 kinase domain of 
various length was designed. Construct of trace soluble expression of RIP3 kinase 
domain was identified by expression screening. Further protein expression process， 
expression strain and purification conditions were optimized. Through affinity 
chromatography-ion exchange two-step purification, milligrams of high purity RIP3 
was available. Size exclusion chromatography analysis indicated the possible 
aggreagte state of RIP3. Finally，through adjusting key factors that influence protein 
state in solution ，we found that the aggregate state of RIP3 kinase domain varied 
with buffer conditions，further influencing its kinase activity. 
















中文摘要 ··································································· I 
英文摘要 ·································································· II 
第一章 前言 ······························································ 1 
1.1 RIP3 蛋白简介 ······························································· 1 
1.1.1 RIP3 所属家族-RIP 家族 ··········································· 1 
1.1.2 RIP3 剪切异构体 ···················································· 2 
1.1.3 RIP3 主要结构域 ···················································· 2 
1.1.4 RIP3 细胞定位 ······················································· 3 
1.2 RIP3 重要生物学功能 ······················································ 4 
1.2.1 RIP3 和细胞凋亡 ···················································· 4 
1.2.2 RIP3 和细胞坏死 ···················································· 6 
1.2.3 RIP3 与 NF-κB 信号通路 ·········································· 6 
1.3 大肠杆菌重组蛋白表达方法 ············································· 8 
1.3.1 大肠杆菌表达系统原理 ············································ 8 
1.3.2 大肠杆菌表达系统高效表达策略 ······························· 10 
1.3.3 大肠杆菌表达系统特点 ··········································· 13 
第二章 材料与方法 ···················································· 15 
2.1 试验材料 ····································································· 15 
2.2 实验主要仪器 ······························································· 16 
2.3 DNA 相关实验和方法 ····················································· 16 
2.3.1 质粒载体 ···························································· 16 
2.3.2 大肠杆菌感受态细胞的制备和转化 ··························· 18 
2.3.3 质粒 DNA 的提取 ················································· 19 
2.3.4 DNA 的限制性内切酶消化 ······································· 20 
2.3.5 DNA 的回收和纯化 ················································ 21 















2.3.7 PCR 反应 ····························································· 24 
2.4 蛋白相关实验方法···························································· 25 
2.4.1 常用试剂的配制 ··················································· 25 
2.4.2 蛋白质定量方法（Bradford 法） ······························ 29 
2.4.3 蛋白的表达和纯化 ················································ 30 
2.4.4 层析方法分析纯化蛋白 ·········································· 32 
2.4.5 激酶活性实验 ······················································ 34 
第三章 结果与分析 ·································································· 35 
3.1 RIP3 初步表达实验 ························································ 35 
3.1.1 RIP3 表达克隆构建 ················································ 35 
3.1.2 RIP3 表达的初步分析 ············································· 36 
3.2 RIP3 基于蛋白表达的序列分析 ········································· 37 
3.2.1 RIP3 总体结构分析 ················································ 37 
3.2.2 .RIP3 C 端二级结构分析·········································· 39 
3.3.RIP3 激酶结构域边界确定 ··············································· 40 
3.3.1 GST 标签 RIP3 激酶结构域表达 ································ 40 
3.3.2 计算机分析 RIP3 激酶结构域 ·································· 40 
3.3.3 小规模蛋白表达试验 ············································· 42 
3.4 RIP3 表达优化 ······························································ 43 
3.4.1 优化表达温度 ······················································ 43 
3.4.2 优化 IPTG 诱导 ···················································· 43 
3.4.3 表达菌株选择 ······················································ 44 
3.5 RIP3 的纯化 ································································ 45 
3.5.1 pH 对 RIP3 纯化的影响 ··········································· 45 
3.5.2 离子交换纯化 RIP3 ··············································· 46 
3.6 RIP3 活性研究 ····························································· 46 
3.6.1 RIP3 激酶活性测定 ················································ 46 
3.6.2 色谱层析分析 RIP3 构象 ········································ 48 















3.7 总结与分析 ·································································· 53 
附录 1 缩略词及中英文对照 ······················································· 55 
附录 2 图表索引 ······································································ 57 

















Table of Contents 
VI 
Table of Contents 
Abstract in Chinese ··························································· III 
Abstract in English ··························································· IV 
Chapter 1 Introduction ························································ 1 
1.1 Introduction of RIP3 protein ······················································ 1 
1.1.1 RIP3 and RIP family ·························································· 1 
1.1.2 Splice variant of RIP3 ························································ 2 
1.1.3 Key domain of RIP3 ·························································· 2 
1.1.4 Cellular location of RIP3 ····················································· 3 
1.2 Biological function of RIP3························································· 4 
1.2.1 RIP3 and apoptosis ···························································· 4 
1.2.2 RIP3 and necrosis ····························································· 6 
1.2.3 RIP3 and NF-κB signal pathway ············································ 6 
1.2.2.1 RIP3 inhibit NF-κB activation ······································ 6 
1.2.2.2 Overexpression of RIP3 induces NF-κB activation ·············· 7 
1.3 E. coli protein expression system ·················································· 8 
1.3.1 Principle of E. coli protein expression system ···························· 8 
1.3.1.1 Operon ·································································· 8 
1.3.1.2 Stringent control ······················································· 9 
1.3.2 Strategies for efficient protein production in E.coli ···················· 10 
1.3.2.1 Construction of expression plasmid ······························ 10 
1.3.2.2 Culture condition ····················································· 11 
1.3.2.3 Expression strain ···················································· 12 
1.3.2.4 protein sequence····················································· 13 
1.3.3 Characteristics of E.coli expression system ····························· 13 
1.3.3.1 Advantage of E.coli expression system ·························· 13 













Table of Contents 
VII 
Chapter 2 Materials and methods ·········································· 15 
2.1 Drugs and reagents ································································ 15 
2.2 Instruments ·········································································· 16 
2.3 Experiments and methods for DNA ············································ 16 
2.3.1 Vector ········································································· 16 
2.3.1.1 pET28a vector ······················································· 16 
2.3.1.2 pGEX4T1vector ····················································· 17 
2.3.2 Preparation of competent cells and transformation ····················· 18 
2.3.2.1 Preparation of competent cells ···································· 18 
2.3.2.2 Transformation of DNA into competent cells ··················· 19 
2.3.3 Preparation of plasmid DNA ·············································· 19 
2.3.3.1 Mini-prep of plasmid DNA by boiling ··························· 19 
2.3.3.2 Midi-prep of plasmid DNA by alkaline lysis ··················· 20 
2.3.4 Enzymatic treatments of plasmid DNA ·································· 20 
2.3.5 Recovery and purification of DNA ······································· 21 
2.3.5.1 Agarose gel electrophoresis ······································· 21 
2.3.5.2 Recovery of DNA from agarose gel ······························ 22 
2.3.6 Ligase independent ligation ················································ 23 
2.3.7 PCR reaction ································································· 24 
2.4 Experiments and methods for protein ········································· 25 
2.4.1 Preparation of solutions ···················································· 25 
2.4.1.1 Preparation of culture medium ···································· 25 
2.4.1.2 Preparation of antibiotics and IPTG solutions ·················· 26 
2.4.1.3 Preparation of solutions for protein electrophoresis ··········· 26 
2.4.1.4 Preparation of solutions for protein purification ··············· 27 
2.4.2 Protein concentration determination(Bradford method） ············· 29 
2.4.3 protein expression and purification ······································· 30 
2.4.3.1 Transformation of BL21(de3) ····································· 30 













Table of Contents 
VIII 
2.4 4 Protein purification and analysis by chromatography ·················· 32 
2.4.5 Kinase assay ·································································· 34 
Chapter 3 Results and analysis ············································· 35 
3.1 Initial trial of RIP3 expression ·················································· 35 
3.1.1 Construction of RIP3 expression plasmid ······························· 35 
3.1.2 RIP3 expression ····························································· 36 
3.2 Analysis of sequence of RIP3for protein expression ························ 37 
3.2.1 Analysis of overall structure of RIP3 ····································· 37 
3.2.2 .Analysis of RIP3 C-terminal ·············································· 39 
3.3 RIP3 kinase domain boundary determination ······························· 40 
3.3.1 GST-RIP3 kinase domain expression ····································· 40 
3.3.2 Analysis of RIP3 kinase domain in silico ································ 40 
3.3.3 Small scale expression screening ········································· 42 
3.4 Optimization of RIP3 expression ··············································· 43 
3.4.1 Optimization of induction temperature ··································· 43 
3.4.2 Optimization of IPTG dose ················································ 43 
3.4.3 Optimization of expression strain ········································· 44 
3.5 Purification of RIP3 ······························································· 45 
3.5.1 pH on RIP3 purification ···················································· 45 
3.5.2 RIP3 purification by ion exchange ········································ 46 
3.6 Investigation of RIP3 activity ···················································· 46 
3.6.1 RIP3 kinase assay ··························································· 46 
3.6.2 RIP3 analysis by chromatography ········································ 48 
3.6.3 Buffer component on RIP3 activity ······································· 49 
3.7 Conclusion and discussion ························································ 53 
Appendix 1 Abbreviations ··················································· 55 
Appendix 2 Index of Figures and tables ··································· 57 
















1.1 RIP3 蛋白简介 








RIP 家族蛋白从结构域组成上看，包含许多不同的结构域，如 RIP1 和 RIP2
含有 DD、CARD 等参与细胞凋亡结构域，RIP6 和 RIP7 含有 LRR 和 Roc/COR
结构域。LRR 结构域参与蛋白之间相互作用。并且激酶结构够分布位置也不同，
RIP1-5 的激酶结构域在 N 端，而 RIP6 和 RIP7 的激酶结构域在中间.相同之处在
于，结构上都具有一段同源性较高的 Ser/Thr 特异的蛋白激酶结。 
 
图 1.1 RIP 家族成员结构[1] 















1.1.2 RIP3 剪切异构体 
随着升研究 RIP3 的深入，Yang Y 等人发现，除了 RIP3 本身之外，在现细
胞内存在另外两种形式的 RIP3：RIP3β 和 RIP3γ[2]，它们源自不同的剪接方式。
区别于全长 RIP3，这两个剪切体均无完整的 N 末端激酶结构域，C 末端比正常
RIP3 短，不具激酶活性，亦缺乏核质穿梭及诱导凋亡能力[2]。 
研究发现 RIP3β 和 RIP3γ 能下调 RIP3 诱导的细胞凋亡。瞬时共转实验发现，
发现 RIP3β 和 RIP3γ 不仅不能诱导细胞凋亡，还使得 RIP3 诱导的细胞凋亡下调
了近一半。目前尚不了解这两个剪切体的具体功能，不过相信对它们的研究将
有助于进一步深入了解 RIP3 的生物学功能。 
实时定量 PCR 分析结果显示，与正常的组织相比，RIP3γ 对 RIP3 的比例
在结肠癌和肺癌细胞中明显升高，RIP3γ 诱导细胞凋亡能力的缺失与肿瘤的发生
可能存在重要的关联[2]。 
1.1.3 RIP3 主要结构域 
RIP 家族属于 TKL 苏氨酸/丝氨酸蛋白激酶家族，蛋白激酶结构域也是该家
族所唯一共有结构域。RIP3 含有两个结构域，N 端激酶结构域和 C 端 RHIM 结
构域。RIP3 的蛋白激酶结构域位于序列的 N 端大约氨基酸 22-292，通过序列比
对发现 RIP3 激酶结构域与家族的其他成员激酶结构域有高度保守性，约有 30%
相同氨基酸、60%相似性氨基酸。 
体外激酶分析实验表明，RIP3 是一个激酶并且会发生自磷酸化[3]。通过定
点突变人源 RIP3 K51 位点可以失活 RIP3 激酶活性[4]，，鼠源 RIP3 的激酶活性中
心位点为 Lys45[5]。但 RIP3 的激酶活性不是其促细胞凋亡作用所必需的，突变
失活的 RIP3 并不影响其通过 TNF 信号通路促进 MCF7 细胞凋亡[3]。RIP3 在
TNF-R1 以及 TRIF 通路中均参与 NF-kB 的激活[6]。通过基因敲除 RIP3，小鼠胸
腺内的 TNF 以及 TLR2 介导的 NF-kB 的激活并没有下调，即此条件下 NF-kB 激
活并不依赖 RIP3。相反，RIP3 通过 C 端 RHIM 结构域与 RIP1 结合，促使其磷
酸化，在此过程中 RIP3 活性及 RHIM 结构域都是必须的。 
















LPS-TRL4 中起作用的 TRIF 蛋白，此外，在细胞巨化病毒也发现含有 RHIM 结
构域的 M45 蛋白。M45 与 RIP1 和 RIP3 之间通过 RHIM 相互作用[7]，并且，通
过 M45 与 RIP１的这种作用可以抑制细胞死亡，其背后的生物学意义在于在小
鼠感染细胞巨化病毒后可以防止病毒成熟前细胞死亡。关于 RIP3 的 RIHM 首先
是由 Sun 等人鉴定出来．通过 RIP3 缺失突变以及丙氨酸突变鉴定出 RIP3 RHIM
最小功能区为 442-472[8]。通过 RHIM 结构域，RIP3 可以和 RIP1 形成符合物，
通过形成符合物以及磷酸化反应，并促经 TNF 诱导的细胞坏死[9]。RHIM 在 RIP3
和 RIP1 形成复合物中起什么作用，目前的生化研究数据尚不多，Sun 等人通过
体外原核表达 RIP1 和 RIP3 来验证 RIP3 和 RIP1 的相互作用。结果表明 RIP1 和
RIP3 的相互作用，不仅依赖 RHIM 核心结构域，两端序列也起辅助作用[3]。另
此外 Jeong 等人通过使用 GST 标签在细菌里表达 RIP3RHIM 结构域的一个 82
个氨基酸片段，经过圆二色谱、荧光色谱，表明 RIP3RHIM 呈α螺旋构像，并
且呈现出温度依赖性构想转化[10]，深入了解 RHIM 的结构信息有助于揭开 RIP3
和 RIP1 等含有 RHIM 结构域的蛋白的功能。 
1.1.4 RIP3 细胞定位 
关于 RIP3 在细胞内的定位至今仍未有统一观点。Yang Y 等人在 Hela 细胞
中过量表达 RIP3，鉴定出 RIP3 的细胞定位序列。在 RIP3 序列上，有一段非经
典的核定位信号（nuclear localization signal，NLS）三段富含亮氨酸的核输出信
号（nuclear export signal，NES），分别为 NLS（氨基酸 442-472）、NES1（氨基
酸 255-264）、NES2（氨基酸 344-354）、NES3 I（氨基酸 116-126）和 NES3 II
（氨基酸 121-131）。RIP3 定位于细胞质，可以通过核定位信号和核输出信号实
现在细胞质和核之间穿梭[11]。 
此外，他们还在发现了 RIP3 的另一种依赖出核介导物 CRM1（chromosome 
region maintenance 1）核质定位方式：在 RIP3 上存在一段非经典的核定位信号，
它和核输出序列NES1 和NES2以CRM1依赖的方式介导RIP3出核。通过CRM1
与出核蛋白上的 NES 序列结合可将其转运至核孔的出核部位；这种 CRM1 依赖
出核方式在 NES1 和 NES2 中存在，NES 则不需要 CRM1 协助。氨基酸 260-268















RIP3 的依赖 CRM1 的出核方式通过出核抑制剂 Leptomycin B（LMB）得到
证明。LMB 是从链霉菌中分离出来的一种不饱和支链脂肪酸，末端带有内酯环，
可以和 CRM1 的一个保守半胱氨酸巯基形成共价化合物，阻止 CRM1 和出核目
标蛋白的 NES 序列相互作用，是一种有效的 CRM1 介导的出核转运的抑制剂[12, 
13]。Hela 细胞中外源表达的 RIP3 在 LMB 处理后，大多定位于细胞核内，说明
RIP3 主要的核输出方式是 CRM1 依赖的，即通过 NES1 和 NES2 实现核质间的
自由穿梭[11] 
Gary M 等人报道则不同，他们认为 RIP3 以点状形式定位于线粒体[14]。他
们通过外源表达的 RIP3 或 RIP1，在细胞内都定位于线粒体，并由此推测二者可
能在线粒体存在相互作用。同时作者还利用特异性抑制剂 Z-DEVD-FMK（抑制
caspase-3、-6、-7、-8、-10）和 caspase 的广谱性抑制剂 zVAD，推测 RIP3 作用
于线粒体上游以激活 caspase，并且认为可能 RIP3 与 RAIDD 蛋白的功能类似，
在线粒体上激活 caspase-2，而不是在 TNF-R1 信号复合体中激活 caspase[14, 15]。 
通过外源表达 RIP3 的 NLS 氨基酸（442-472）可以诱导细胞凋亡，Yang Y
等人据此推断核定位与 RIP3 诱导细胞凋亡有关[11]。这与之前关于 TRADD 和
FADD 能在细胞核内诱导细胞凋亡[16-18]报道类似。此外 p53 和 APC（adenomatous 
polyposis coli）等抑癌因子功能也受到自身核质穿梭能力的调节[19, 20]。此外，Sun 
X 等人指出外源 RIP3 在 TNF 刺激下与内源 RIP1 共定位于 TNF-R1 信号符合物
上，并且通过磷酸化 RIP1 调控 NF-κB 活化[8]。 
综上所述，RIP3 的定位还需要通过进一步研究确定，不过可以肯定 RIP3
的亚细胞定位与其所执行的功能密切相关。 
1.2 RIP3 重要生物学功能 
1.2.1 RIP3 和细胞凋亡 
RIP3 广泛表达于胚胎和大量的成熟组织中。它所定位的染色体区域是肿瘤
发生中多发基因突变的区域，提示RIP3对肿瘤的形成或存活有着重要的影响[14]。















RIP3 很早被鉴定出过量表达会诱导细胞凋亡的蛋白激酶[5,6,21]。在 Hela 细
胞、Phoenix-A 细胞（一株包装逆转录病毒的 293T 细胞）、MCF-7 乳腺癌细胞
（breast carcinoma cells）和 293E 肾上皮细胞（293E renal epithelial cells）中过量
表达 RIP3，会引起细胞死亡。并且形态学特征与细胞凋亡一致，同时检 caspase
也会被激活，即过量表达 RIP3 能引起 caspase 依赖的细胞凋亡[3]。通过实验进一
步发现，该细胞凋亡的发生依赖于 RIP3 的 C 末端，但其激酶活性区以及 RIP3
与 RIP1 相互作用的 RHIM 结构域[5,14]不是必须的。 
用 TNF 处理过量表达 RIP3 的细胞后，发现 C 末端缺失的 RIP3 能够抑制
TNF 诱导的 caspase 的激活，但不影响 TNF 引发的 NF-κB 信号通路，即 RIP3
的 C 末端可能在 TNF 诱导的 caspase 依赖的细胞凋亡途径中发挥着重要的功能
[3]。 
RIP1 在 TNF 诱导的细胞凋亡过程中可被 caspase-8 在 Asp32 位点剪切[22,23]。
剪切之后，RIP1 的 C 末端不能激活 NF-κB，从而进一步加强细胞凋亡[23]。RIP3
也存在类似机制。在电网诱导因子作用下，RIP3 会在 Asp328 出被 caspase-8 剪
切。剪切后的 C 末端虽然缺乏激酶活性区，但能诱导 caspase 依赖的细胞凋亡。
不同之处在于，RIP3C 末端表现出比全长 RIP3 更强的 NF-κB 激活能力[24]。因此
RIP3 被剪切被认为是细胞自我保护的反馈机制。 
虽然 RIP3 过量表达会导致 caspase 依赖的细胞凋亡已经很确定，但 RIP3 参
与哪条死亡途径以及它在信号通路中确切的定位人们还不了解。Kasof GM 等人
指出，Hela 细胞中过表达 RIP3 会诱导细胞凋亡，而 RIP3 可能位于 Bcl-2 家族
成员的上游。同时他们通过使用多种 caspase 抑制剂对信号通路进行抑制，认为
caspase-2、-3、-7、-10 为此凋亡途径所必需[14]。和 RIP1 诱导的细胞凋亡途径相
比较，细胞凋亡过程中 RIP3 对 caspase-2 的依赖有相似之处，RIP1 通过 RAIDD
结合 caspase-2 而使其活化[25, 26]。 
TNF-R1 介导细胞凋亡过程中 FADD 起重要作用，但它不是 TNF 诱导凋亡
的唯一途径[27, 28]。共转染的显性负突变（dominant-negative mutant）的 FADD
（DN-FADD）并不能抑制 RIP3 过量表达诱导的细胞死亡。但在 RIP3 显性负突
变却一定程度抑制 TNF-R1 诱导的细胞死亡[3]。这些实验提示 RIP3 可能位于细
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